GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback